+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Global Orthobiologics Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts, 2018 To 2026

  • ID: 4701656
  • Report
  • Region: Global
  • Acute Market Reports
1 of 4

FEATURED COMPANIES

  • Arthrex Inc.
  • Bioventus LLC
  • Globus Medical Inc.
  • K2M Group Holdings Inc.
  • Kuros Biosciences Ltd.
  • Medtronic PLC
  • MORE
Orthobiologics Market - Growth, Future Prospects, Competitive Analysis, 2018 - 2026, the global orthobiologics market was valued at US$ 4,919.0 Mn in 2017 expanding at a CAGR of 5.7% from 2018 to 2026.

Market Insights
Orthobiologics is minimally invasive procedure using biological substance to fasten the healing process during an injury. Orthobiologics have shown to improve healing of musculoskeletal injuries such as fractures, injured muscle, ligaments and tendons. Orthobiologics include range of treatment using patient’s own tissue or stem cells to produce proteins in order to artificially regenerate injured muscles. There has been a heightened usage of orthobiologics in the last two decades due to better understanding of biologics, technological advancements and skills required for the treatment; thus emerging as an significant sector in shaping the future of regenerative medicines and cellular therapies. Moreover, growing application of orthobiologics in osteoarthritis and sport medicine is the major driver for the growth of the market. Other factors that are supporting the growth of orthobiologics market include growing geriatric population susceptible for orthopedic disorders, growing rate of obesity and musculoskeletal injuries and increasing patient inclination towards minimally invasive therapies. However, high costs associated with treatment and products are the prime factor restraining the growth of global orthobiologics market.

In terms of product, viscosupplementation products held the largest share in the global orthobiologics market. Viscosupplementation also called as hyaluronic injection is the most commonly used procedure to treat osteoarthritis. The U.S. Food and Drug Administration (FDA) has approved viscosupplementation of knee arthritis only, however, it can be used for hip and other joint arthritis as off label therapy. Growing prevalence of osteoarthritis in the geriatric population is the key driver for the growth of this market. Aging is responsible for carrying out alterations in the musculoskeletal system, which tends to increase the propensity to osteoarthritis. According to Centers for Disease Prevention and Control (CDC), an estimate of 78.4 million adults aged 18 years or above will have doctor-diagnosed arthritis by 2040 in the U.S., as compared to 54.4 million adults in 2013 to 2015.These factors will further drive the growth of global orthobiologics market during the forecast period.

North America held the pole position in terms of geography in global orthobiologics market. The key drivers that will facilitate the growth of the orthobiologics market in North America are presence of giant players operating in the market, increasing number of elderly population suffering with orthopedic degenerative diseases and flourishing research and development opportunities due to strategic partnerships and collaborations between research institutes and biopharmaceutical companies engaged in novel cellular therapies for orthopedic treatment.

Asia Pacific expected to grow at fastest rate during the forecast period owing to presence of high geriatric population and patient pool, increasing government spending and flourishing sports medicine in the region. Rising medical tourism in the region will further assist the growth of orthobiologics market during the forecast period. The prominent players actively engaged in the orthobiologics market include DePuy Synthes, Stryker Corporation, Medtronic plc, NuVasive Inc., Zimmer Biomet, Globus Medical, Inc., Orthofix Internamtional NV, Harvest Technologies Corporation, Seaspine Holdings Corporation, RTI Surgicals among others.

Key Market Movements:
  • Growing inclination towards orthobiologics and cellular therapies in sports medicine
  • Growing prevalence of osteoarthritis and number of spinal fusion surgeries globally
  • Growing preference of minimally invasive therapies by patients, especially in the developed countries
  • Technological advancements and R&D in cellular arthoplasty for the treatment of orthopedic ailments
Note: Product cover images may vary from those shown
2 of 4

FEATURED COMPANIES

  • Arthrex Inc.
  • Bioventus LLC
  • Globus Medical Inc.
  • K2M Group Holdings Inc.
  • Kuros Biosciences Ltd.
  • Medtronic PLC
  • MORE
Chapter 1. Preface
1.1. Report Description
1.1.1. Study Purpose
1.1.2. Target Audience
1.1.3. USP and Key Offerings
1.2. Research Scope
1.3. Research Methodology
1.3.1. Phase I – Secondary Research
1.3.2. Phase II – Primary Research
1.3.3. Phase III – Expert Panel Review
1.3.4. Assumptions
1.4. Market Segmentation

Chapter 2. Executive Summary
2.1. Global Orthobiologics Market Portraiture
2.2. Global Orthobiologics Market, by Product Type, 2017 (US$ Mn)
2.3. Global Orthobiologics Market, by Application, 2017 (US$ Mn)
2.4. Global Orthobiologics Market, by Geography, 2017 (US$ Mn)

Chapter 3. Orthobiologics: Market Dynamics and Outlook
3.1. Market Overview
3.2. Drivers
3.3. Challenges
3.4. Opportunities
3.5. Attractive Investment Proposition, by Geography, 2017
3.6. Competitive Analysis: Global Orthobiologics Market, by Key Players, 2017

Chapter 4. Global Orthobiologics Market, by Product Type, 2016-2026 (US$ Mn)
4.1. Overview
4.2. Viscosupplementation Products
4.3. Demineralized Bone Matrices
4.4. Synthetic Orthobiologics
4.5. Bone Morphogenic Protein
4.6. Allografts
4.7. Plasma-Rich Protein
4.8. Bone Marrow Aspirate Concentrate

Chapter 5. Global Orthobiologics Market, by Application, 2016-2026 (US$ Mn)
5.1. Overview
5.2. Osteoarthritis and Degenerative Arthritis
5.3. Spinal Fusion
5.4. Soft-Tissue Injuries
5.5. Fracture Recovery
5.6. Maxillofacial and Dental Applications

Chapter 6. Global Orthobiologics Market, by Geography, 2016 – 2026 (US$ Mn)
6.1. North America Orthobiologics Market Analysis, 2016 – 2026
6.1.1. North America Orthobiologics Market, by Product Type, 2016 - 2026 (US$ Mn)
6.1.2. North America Orthobiologics Market, by Application, 2016 - 2026 (US$ Mn)
6.1.3. North America Orthobiologics Market, by Country, 2016 – 2026 (US$ Mn)
6.1.3.1. U.S.
6.1.3.2. Canada
6.2. Europe Orthobiologics Market Analysis, 2016 – 2026
6.2.1. Europe Orthobiologics Market, by Product Type, 2016 - 2026 (US$ Mn)
6.2.2. Europe Orthobiologics Market, by Application, 2016 - 2026 (US$ Mn)
6.2.3. Europe Orthobiologics Market, by Country, 2016 – 2026 (US$ Mn)
6.2.3.1. U.K.
6.2.3.2. Germany
6.2.3.3. Rest of Europe
6.3. Asia Pacific Orthobiologics Market Analysis, 2016 – 2026
6.3.1. Asia Pacific Orthobiologics Market, by Product Type, 2016 - 2026 (US$ Mn)
6.3.2. Asia Pacific Orthobiologics Market, by Application, 2016 - 2026 (US$ Mn)
6.3.3. Asia Pacific Orthobiologics Market, by Country, 2016 – 2026 (US$ Mn)
6.3.3.1. China
6.3.3.2. Japan
6.3.3.3. India
6.3.3.4. Rest of Asia Pacific
6.4. Latin America Orthobiologics Market Analysis, 2016 – 2026
6.4.1. Latin America Orthobiologics Market, by Product Type, 2016 - 2026 (US$ Mn)
6.4.2. Latin America Orthobiologics Market, by Application, 2016 - 2026 (US$ Mn)
6.4.3. Latin America Orthobiologics Market, by Country, 2016 – 2026 (US$ Mn)
6.4.3.1. Brazil
6.4.3.2. Mexico
6.4.3.3. Rest of Latin America
6.5. Middle East & Africa Orthobiologics Market, 2016 – 2026
6.5.1. Middle East & Africa Orthobiologics Market, by Product Type, 2016 - 2026 (US$ Mn)
6.5.2. Middle East & Africa Orthobiologics Market, by Application, 2016 - 2026 (US$ Mn)
6.5.3. Middle East & Africa Orthobiologics Market, by Country, 2016 – 2026 (US$ Mn)
6.5.3.1. GCC
6.5.3.2. Rest of Middle East & Africa

Chapter 7. Company Profiles
7.1. Depuy Synthes (A Subsidiary of Johnson & Johnson)
7.1.1. Business Description
7.1.2. Financial Information (Subject to Data Availability)
7.1.3. Product Portfolio
7.1.4. News Coverage
7.2. Arthrex Inc.
7.3. Bioventus LLC
7.4. Globus Medical Inc.
7.5. Harvest Technologies Corporation (A Terumo Bct Company)
7.6. K2M Group Holdings Inc.
7.7. Kuros Biosciences Ltd.
7.8. Medtronic PLC
7.9. Nuvasive Inc.
7.10. Orthofix International NV
7.11. RTI Surgical Inc.
7.12. Stryker Corporation
7.13. Zimmer Biomet
7.14. Seaspine Holdings Corporation

List of Figures
FIG 1. Orthobiologics Market: Research Methodology
FIG 2. Orthobiologics: Market Segmentation
FIG 3. Global Orthobiologics Market, by Product Type, 2017 (US$ Mn)
FIG 4. Global Orthobiologics Market, by Application Type, 2017 (US$ Mn)
FIG 5. Global Orthobiologics Market, by Geography, 2017 (US$ Mn)
FIG 6. Attractive Investment Proposition, by Geography, 2017
FIG 7. Competitive Analysis: Global Orthobiologics Market, by Key Players, 2017
FIG 8. Global Viscosupplementation Products Market, 2016-2026 (US$ Mn)
FIG 9. Global Demineralized Bone Matrices Market, 2016-2026(US$ Mn)
FIG 10. Global Synthetic Orthobiologics Market, 2016-2026(US$ Mn)
FIG 11. Global Bone Morphogenic Protein Market, 2016-2026(US$ Mn)
FIG 12. Global Allografts Market, 2016-2026(US$ Mn)
FIG 13. Global Plasma-Rich Protein Market, 2016-2026(US$ Mn)
FIG 14. Global Bone Marrow Aspirate Concentrate Market, 2016-2026(US$ Mn)
FIG 15. Global Orthobiologics Market for Osteoarthritis and Degenerative Arthritis, 2016-2026 (US$ Mn)
FIG 16. Global Orthobiologics Market for Spinal Fusion, 2016-2026(US$ Mn)
FIG 17. Global Orthobiologics Market for Soft-Tissue Injuries, 2016-2026 (US$ Mn)
FIG 18. Global Orthobiologics Market for Fracture Recovery, 2016-2026 (US$ Mn)
FIG 19. Global Orthobiologics Market for Maxillofacial and Dental Applications, 2016-2026 (US$ Mn)
FIG 20. U.S. Orthobiologics Market, 2016-2026 (US$ Mn)
FIG 21. Canada Orthobiologics Market, 2016-2026 (US$ Mn)
FIG 22. U.K. Orthobiologics Market, 2016-2026 (US$ Mn)
FIG 23. Germany Orthobiologics Market, 2016-2026 (US$ Mn)
FIG 24. Rest of Europe Orthobiologics Market, 2016-2026 (US$ Mn)
FIG 25. China Orthobiologics Market, 2016-2026 (US$ Mn)
FIG 26. Japan Orthobiologics Market, 2016-2026 (US$ Mn)
FIG 27. South Korea Orthobiologics Market, 2016-2026 (US$ Mn)
FIG 28. Rest of Asia Pacific Orthobiologics Market, 2016-2026 (US$ Mn)
FIG 29. Brazil Orthobiologics Market, 2016-2026 (US$ Mn)
FIG 30. Mexico Orthobiologics Market, 2016-2026 (US$ Mn)
FIG 31. Rest of Latin America Orthobiologics Market, 2016-2026 (US$ Mn)
FIG 32. GCC Orthobiologics Market, 2016-2026 (US$ Mn)
FIG 33. Rest of Middle East & Africa Orthobiologics Market, 2016-2026 (US$ Mn)

List of Tables
TABLE 1 Global Orthobiologics Market Portraiture
TABLE 2 Global Orthobiologics Market, by Product Type, 2016 – 2026 (US$ Mn)
TABLE 3 Global Orthobiologics Market, by Application, 2016 – 2026 (US$ Mn)
TABLE 4 Global Orthobiologics Market, by Geography, 2016 – 2026 (US$ Mn)
TABLE 5 North America Orthobiologics Market, by Product Type, 2016 – 2026 (US$ Mn)
TABLE 6 North America Orthobiologics Market, by Application, 2016 – 2026 (US$ Mn)
TABLE 7 North America Orthobiologics Market, by Country, 2016 – 2026 (US$ Mn)
TABLE 8 Europe Orthobiologics Market, by Product Type, 2016 – 2026 (US$ Mn)
TABLE 9 Europe Orthobiologics Market, by Application, 2016 – 2026 (US$ Mn)
TABLE 10 Europe Orthobiologics Market, by Country/Region, 2016 – 2026 (US$ Mn)
TABLE 11 Asia Pacific Orthobiologics Market, by Product Type, 2016 – 2026 (US$ Mn)
TABLE 12 Asia Pacific Orthobiologics Market, by Application, 2016 – 2026 (US$ Mn)
TABLE 13 Asia Pacific Orthobiologics Market, by Country/Region, 2016 – 2026 (US$ Mn)
TABLE 14 Latin America Orthobiologics Market, by Product Type, 2016 – 2026 (US$ Mn)
TABLE 15 Latin America Orthobiologics Market, by Application Type, 2016 – 2026 (US$ Mn)
TABLE 16 Latin America Orthobiologics Market, by Country/Region, 2016 – 2026 (US$ Mn)
TABLE 17 Middle East & Africa Orthobiologics Market, by Product Type, 2016 – 2026 (US$ Mn)
TABLE 18 Middle East & Africa Orthobiologics Market, by Application, 2016 – 2026 (US$ Mn)
TABLE 19 Middle East & Africa Orthobiologics Market, by Region, 2016 – 2026 (US$ Mn)
TABLE 20 Depuy Synthes (A Subsidiary of Johnson & Johnson): Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
TABLE 21 Arthrex Inc.: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
TABLE 22 Bioventus LLC: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
TABLE 23 Globus Medical Inc.: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
TABLE 24 Harvest Technologies Corporation (A Terumo Bct Company): Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
TABLE 25 K2M Group Holdings Inc.: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
TABLE 26 Kuros Biosciences Ltd.: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
TABLE 27 Medtronic PLC: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
TABLE 28 Nuvasive Inc.: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
TABLE 29 Orthofix International NV: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
TABLE 30 RTI Surgical Inc.: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
TABLE 31 Stryker Corporation: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
TABLE 32 Zimmer Biomet: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
TABLE 33 Seaspine Holdings Corporation: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
Note: Product cover images may vary from those shown
3 of 4

Loading
LOADING...

4 of 4
  • Depuy Synthes (A Subsidiary of Johnson & Johnson)
  • Arthrex Inc.
  • Bioventus LLC
  • Globus Medical Inc.
  • Harvest Technologies Corporation (A Terumo Bct Company)
  • K2M Group Holdings Inc.
  • Kuros Biosciences Ltd.
  • Medtronic PLC
  • Nuvasive Inc.
  • Orthofix International NV
  • RTI Surgical Inc.
  • Stryker Corporation
  • Zimmer Biomet
  • Seaspine Holdings Corporation
Note: Product cover images may vary from those shown
5 of 4
Note: Product cover images may vary from those shown
Order Online - visit: https://www.researchandmarkets.com/reports/4701656
Adroll
adroll